0
Precision BioSciences, Inc. Banner Image

Precision BioSciences, Inc. has reached its limit for free report views

Work for Precision BioSciences, Inc.? Upgrade Your Profile and unlock all your annual reports.

Precision BioSciences, Inc.

  • Ticker DTIL
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Precision BioSciences, Inc. Logo Image
  • 201-500 Employees
  • Based in Durham, North Carolina
Precision BioSciences, Inc. is a clinical stage biotechnology company dedicated to improving life (DTIL) with its novel and proprietary ARCUS® genome editing platform. ARCUS is a highly specific and versatile genome editing platform that was designed with therapeutic safety, delivery, and control in mind. Using ARCUS, the Company’s pipeline consists of multiple “off-the-shelf” CAR T immunotherapyMore clinical candidates and several in vivo gene correction therapy candidates to cure genetic and infectious diseases where no adequate treatments exist.
Precision BioSciences, Inc.

Most Recent Annual Report

Precision BioSciences, Inc. MOST RECENT 2019 Annual Report and Form 10K

Report Locked. Precision BioSciences, Inc. has reached its limit for free report views.